当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2020-04-01 , DOI: 10.1002/ejhf.1796
Chris J Kapelios 1 , Cécile Laroche 2 , Maria G Crespo-Leiro 3 , Stefan D Anker 4 , Andrew J S Coats 5 , Beatria Díaz-Molina 6 , Gerasimos Filippatos 7 , Mitja Lainscak 8 , Aldo P Maggioni 2, 9 , Theresa McDonagh 10 , Alexandre Mebazaa 11 , Marco Metra 12 , Brenda Moura 13 , Wilfried Mullens 14 , Massimo F Piepoli 15 , Giuseppe M C Rosano 5 , Frank Ruschitzka 16 , Petar M Seferovic 17 , Lars H Lund 18 ,
Affiliation  

Guidelines recommend down‐titration of loop diuretics (LD) once euvolaemia is achieved. In outpatients with heart failure (HF), we investigated LD dose changes in daily cardiology practice, agreement with guideline recommendations, predictors of successful LD down‐titration and association between dose changes and outcomes.

中文翻译:

慢性心力衰竭的loop利尿剂剂量变化与预后之间的关联:ESC-EORP心力衰竭长期注册中心的观察

指南建议在达到尿毒症血症后滴定loop利尿剂(LD)。在心力衰竭(HF)的门诊患者中,我们调查了日常心脏病学实践中的LD剂量变化,与指南建议的一致性,LD滴定成功的预测因素以及剂量变化与结果之间的关联。
更新日期:2020-04-01
down
wechat
bug